| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 NLRP10 ERCC6 DNAH10 MYO5B ERCC6L2 YTHDC2 SMARCAD1 SMC2 HELQ KIF11 DHX9 | 5.01e-06 | 614 | 79 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC6 POLR1A XRN1 ERCC6L2 DARS1 YTHDC2 SMARCAD1 HELQ DIS3 TOE1 DHX9 TGS1 | 8.25e-06 | 645 | 79 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 NLRP10 ERCC6 DNAH10 MYO5B YTHDC2 SMARCAD1 SMC2 HELQ DHX9 | 9.22e-06 | 441 | 79 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | 3.85e-05 | 158 | 79 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | single-stranded 3'-5' DNA helicase activity | 4.62e-05 | 3 | 79 | 2 | GO:1990518 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.49e-04 | 127 | 79 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH7 NLRP10 ERCC6 DNAH10 MYO5B GNB5 YTHDC2 SMARCAD1 SMC2 HELQ DHX9 | 2.28e-04 | 775 | 79 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 2.29e-04 | 6 | 79 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.42e-04 | 417 | 79 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.20e-04 | 37 | 79 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH7 NLRP10 ERCC6 DNAH10 MYO5B GNB5 YTHDC2 SMARCAD1 SMC2 HELQ DHX9 | 4.48e-04 | 839 | 79 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH7 NLRP10 ERCC6 DNAH10 MYO5B GNB5 YTHDC2 SMARCAD1 SMC2 HELQ DHX9 | 4.53e-04 | 840 | 79 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH7 NLRP10 ERCC6 DNAH10 MYO5B GNB5 YTHDC2 SMARCAD1 SMC2 HELQ DHX9 | 4.53e-04 | 840 | 79 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 5.30e-04 | 40 | 79 | 3 | GO:0016896 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 7.50e-04 | 45 | 79 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | siRNA binding | 9.94e-04 | 12 | 79 | 2 | GO:0035197 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.24e-03 | 118 | 79 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.79e-03 | 16 | 79 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.91e-03 | 62 | 79 | 3 | GO:0003678 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.91e-03 | 62 | 79 | 3 | GO:0016796 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.97e-03 | 134 | 79 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.18e-03 | 65 | 79 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 2.27e-03 | 18 | 79 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 3.70e-03 | 23 | 79 | 2 | GO:0017116 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.83e-03 | 262 | 79 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 4.72e-03 | 26 | 79 | 2 | GO:0097602 | |
| GeneOntologyMolecularFunction | exonuclease activity | 5.81e-03 | 92 | 79 | 3 | GO:0004527 | |
| Domain | Helicase_C | 6.54e-06 | 107 | 80 | 6 | PF00271 | |
| Domain | HELICc | 6.54e-06 | 107 | 80 | 6 | SM00490 | |
| Domain | Helicase_C | 6.90e-06 | 108 | 80 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 7.28e-06 | 109 | 80 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.28e-06 | 109 | 80 | 6 | PS51192 | |
| Domain | DEXDc | 7.28e-06 | 109 | 80 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 7.67e-06 | 110 | 80 | 6 | IPR014001 | |
| Domain | DCN-prot | 1.80e-04 | 5 | 80 | 2 | IPR014764 | |
| Domain | PONY_dom | 1.80e-04 | 5 | 80 | 2 | IPR005176 | |
| Domain | DCUN1 | 1.80e-04 | 5 | 80 | 2 | PS51229 | |
| Domain | Cullin_binding | 1.80e-04 | 5 | 80 | 2 | PF03556 | |
| Domain | P-loop_NTPase | MYH7 NLRP10 ERCC6 DNAH10 MYO5B ERCC6L2 YTHDC2 SMARCAD1 SMC2 HELQ KIF11 DHX9 | 2.49e-04 | 848 | 80 | 12 | IPR027417 |
| Domain | SNF2_N | 3.43e-04 | 32 | 80 | 3 | IPR000330 | |
| Domain | SNF2_N | 3.43e-04 | 32 | 80 | 3 | PF00176 | |
| Domain | DEAH_ATP_HELICASE | 5.73e-04 | 38 | 80 | 3 | PS00690 | |
| Domain | tRNA_anti-codon | 1.16e-03 | 12 | 80 | 2 | PF01336 | |
| Domain | NA-bd_OB_tRNA | 1.16e-03 | 12 | 80 | 2 | IPR004365 | |
| Domain | Spectrin_alpha_SH3 | 1.83e-03 | 15 | 80 | 2 | IPR013315 | |
| Domain | BAR | 1.83e-03 | 15 | 80 | 2 | SM00721 | |
| Domain | BAR | 1.83e-03 | 15 | 80 | 2 | PF03114 | |
| Domain | BAR_dom | 2.09e-03 | 16 | 80 | 2 | IPR004148 | |
| Domain | DUF1605 | 2.36e-03 | 17 | 80 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.36e-03 | 17 | 80 | 2 | PF07717 | |
| Domain | UBA-like | 2.61e-03 | 64 | 80 | 3 | IPR009060 | |
| Domain | HA2 | 2.65e-03 | 18 | 80 | 2 | SM00847 | |
| Domain | HA2 | 2.65e-03 | 18 | 80 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 2.65e-03 | 18 | 80 | 2 | IPR007502 | |
| Domain | BAR | 2.96e-03 | 19 | 80 | 2 | PS51021 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.79e-03 | 73 | 80 | 3 | IPR011545 | |
| Domain | DEAD | 3.79e-03 | 73 | 80 | 3 | PF00270 | |
| Domain | Actinin_actin-bd_CS | 4.32e-03 | 23 | 80 | 2 | IPR001589 | |
| Domain | Spectrin | 4.32e-03 | 23 | 80 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.32e-03 | 23 | 80 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.32e-03 | 23 | 80 | 2 | PS00019 | |
| Domain | - | 4.54e-03 | 746 | 80 | 9 | 3.40.50.300 | |
| Domain | SH3_1 | 5.40e-03 | 164 | 80 | 4 | PF00018 | |
| Domain | NA-bd_OB-fold | 5.44e-03 | 83 | 80 | 3 | IPR012340 | |
| Domain | SH3_2 | 6.00e-03 | 86 | 80 | 3 | IPR011511 | |
| Domain | SH3_2 | 6.00e-03 | 86 | 80 | 3 | PF07653 | |
| Domain | Spectrin_repeat | 6.82e-03 | 29 | 80 | 2 | IPR002017 | |
| Domain | - | 7.29e-03 | 30 | 80 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 7.29e-03 | 30 | 80 | 2 | IPR027267 | |
| Domain | Spectrin/alpha-actinin | 8.27e-03 | 32 | 80 | 2 | IPR018159 | |
| Domain | SPEC | 8.27e-03 | 32 | 80 | 2 | SM00150 | |
| Domain | - | 8.50e-03 | 679 | 80 | 8 | 3.30.160.60 | |
| Pubmed | PWWP2A MIS18BP1 DST ZFYVE16 ERC1 XRN1 GON4L SGO2 CKAP2 SPEN KIF11 | 3.49e-07 | 645 | 82 | 11 | 25281560 | |
| Pubmed | 5.20e-07 | 407 | 82 | 9 | 12693553 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ERCC6 DST MYO5B ERC1 SGPL1 DARS1 YTHDC2 CKAP2 SMC2 SPEN TOE1 KIF11 TASOR2 DHX9 | 1.34e-06 | 1257 | 82 | 14 | 36526897 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EXOC6 ERCC6 POLR1A XRN1 AGGF1 SGO2 DARS1 YTHDC2 CKAP2 SMC2 DHX9 | 1.71e-06 | 759 | 82 | 11 | 35915203 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | POLR1A DNAH10 SYNE1 SGO2 DARS1 YTHDC2 SMARCAD1 SMC2 SPEN RPA2 DIS3 TOE1 KIF11 DHX9 | 5.71e-06 | 1425 | 82 | 14 | 30948266 |
| Pubmed | NRIP1 DST TRPM7 ERC1 SYNE1 ZNF343 DARS1 NCKAP5 SMARCAD1 DZIP1 ZNF227 CKAP2 ZNF292 | 9.40e-06 | 1285 | 82 | 13 | 35914814 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.02e-05 | 208 | 82 | 6 | 33230847 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 ERCC6 DST POLR1A SGPL1 XRN1 DARS1 SMARCAD1 SMC2 DIS3 TOE1 KIF11 DHX9 | 1.62e-05 | 1353 | 82 | 13 | 29467282 |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 15919751 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 10535961 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 35305312 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 38416570 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 29033321 | ||
| Pubmed | 1.89e-05 | 634 | 82 | 9 | 34591612 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.32e-05 | 497 | 82 | 8 | 36774506 | |
| Pubmed | MYH7 DST MYO5B ERC1 FAM186A SYNE1 XRN1 SMC2 SPEN KIF11 DOP1A TASOR2 ZNF292 | 3.15e-05 | 1442 | 82 | 13 | 35575683 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9122235 | ||
| Pubmed | Synaptojanin and Endophilin Mediate Neck Formation during Ultrafast Endocytosis. | 3.28e-05 | 4 | 82 | 2 | 29953872 | |
| Pubmed | Endophilin-A coordinates priming and fusion of neurosecretory vesicles via intersectin. | 3.28e-05 | 4 | 82 | 2 | 32152276 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 10816441 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9238017 | ||
| Pubmed | LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. | 3.28e-05 | 4 | 82 | 2 | 22998870 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ORC2 NRIP1 MIS18BP1 SLF1 POLR1A ZNF41 SMARCD1 ZNF236 SPEN ZNF292 | 4.10e-05 | 877 | 82 | 10 | 20211142 |
| Pubmed | PWWP2A ERCC6 DST POLR1A SGPL1 SYNE1 ARHGEF9 XRN1 GON4L YTHDC2 CKAP2 SPEN TOE1 | 4.63e-05 | 1497 | 82 | 13 | 31527615 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 5.29e-05 | 724 | 82 | 9 | 36232890 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 16289749 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 12034747 | ||
| Pubmed | Addition of poly(A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells. | 5.47e-05 | 5 | 82 | 2 | 20368444 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 25471590 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 27720640 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.93e-05 | 934 | 82 | 10 | 33916271 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 7.05e-05 | 582 | 82 | 8 | 20467437 | |
| Pubmed | 7.51e-05 | 183 | 82 | 5 | 36129980 | ||
| Pubmed | 7.51e-05 | 183 | 82 | 5 | 23956138 | ||
| Pubmed | Binding properties of SH3 peptide ligands identified from phage-displayed random peptide libraries. | 8.19e-05 | 6 | 82 | 2 | 9238627 | |
| Pubmed | Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. | 8.19e-05 | 6 | 82 | 2 | 10597256 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 10764144 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 23756462 | ||
| Pubmed | Endophilin, Lamellipodin, and Mena cooperate to regulate F-actin-dependent EGF-receptor endocytosis. | 8.19e-05 | 6 | 82 | 2 | 24076656 | |
| Pubmed | Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. | 8.19e-05 | 6 | 82 | 2 | 23187129 | |
| Pubmed | A novel SH3-containing human gene family preferentially expressed in the central nervous system. | 8.19e-05 | 6 | 82 | 2 | 9169142 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 9.54e-05 | 608 | 82 | 8 | 36089195 | |
| Pubmed | 1.11e-04 | 199 | 82 | 5 | 36688959 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 25771685 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 10542231 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.14e-04 | 7 | 82 | 2 | 29758057 | |
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 23667505 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 15988528 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 9341169 | ||
| Pubmed | 1.23e-04 | 469 | 82 | 7 | 37314180 | ||
| Pubmed | GPD1L DST MYO5B ERC1 SGPL1 SYNE1 GNB5 GKAP1 XRN1 DARS1 YTHDC2 DHX9 | 1.30e-04 | 1431 | 82 | 12 | 37142655 | |
| Pubmed | 1.43e-04 | 210 | 82 | 5 | 16565220 | ||
| Pubmed | 1.51e-04 | 650 | 82 | 8 | 38777146 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 20064468 | ||
| Pubmed | Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. | 1.52e-04 | 8 | 82 | 2 | 18602463 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 20888340 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 16115810 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 22099461 | ||
| Pubmed | 1.76e-04 | 497 | 82 | 7 | 23414517 | ||
| Pubmed | CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. | 1.96e-04 | 9 | 82 | 2 | 12177062 | |
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 11254741 | ||
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 21358275 | ||
| Pubmed | 2.06e-04 | 227 | 82 | 5 | 26410627 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.23e-04 | 363 | 82 | 6 | 14691545 | |
| Pubmed | OGFRL1 DCUN1D1 ZNF341 SGPL1 SH3GL3 LGR4 CKAP2 DIS3 KIF11 TGS1 | 2.33e-04 | 1084 | 82 | 10 | 11544199 | |
| Pubmed | 2.36e-04 | 234 | 82 | 5 | 36243803 | ||
| Pubmed | E3 ligase RFWD3 participates in replication checkpoint control. | 2.44e-04 | 10 | 82 | 2 | 21504906 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 2.51e-04 | 701 | 82 | 8 | 30196744 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 2.59e-04 | 704 | 82 | 8 | 29955894 | |
| Pubmed | 2.69e-04 | 708 | 82 | 8 | 39231216 | ||
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 12456676 | ||
| Pubmed | The centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stability. | 2.98e-04 | 11 | 82 | 2 | 27621083 | |
| Pubmed | The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. | 2.98e-04 | 11 | 82 | 2 | 11894096 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.45e-04 | 394 | 82 | 6 | 27248496 | |
| Pubmed | The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. | 3.57e-04 | 12 | 82 | 2 | 19617556 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.64e-04 | 398 | 82 | 6 | 35016035 | |
| Pubmed | 3.92e-04 | 60 | 82 | 3 | 20682791 | ||
| Pubmed | 4.04e-04 | 263 | 82 | 5 | 34702444 | ||
| Pubmed | 4.21e-04 | 13 | 82 | 2 | 23201271 | ||
| Pubmed | 4.21e-04 | 13 | 82 | 2 | 20541997 | ||
| Pubmed | 4.71e-04 | 152 | 82 | 4 | 34299191 | ||
| Pubmed | 4.72e-04 | 418 | 82 | 6 | 34709266 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.85e-04 | 588 | 82 | 7 | 38580884 | |
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 26553929 | ||
| Pubmed | Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. | 4.91e-04 | 14 | 82 | 2 | 26166704 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 5.32e-04 | 157 | 82 | 4 | 30686591 | |
| Pubmed | Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. | 5.65e-04 | 15 | 82 | 2 | 9630982 | |
| Pubmed | 5.65e-04 | 15 | 82 | 2 | 25735744 | ||
| Pubmed | 5.65e-04 | 15 | 82 | 2 | 19762545 | ||
| Pubmed | 5.91e-04 | 608 | 82 | 7 | 16713569 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.17e-04 | 440 | 82 | 6 | 34244565 | |
| Pubmed | 6.45e-04 | 16 | 82 | 2 | 24586484 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 6.85e-04 | 168 | 82 | 4 | 30631154 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 6.88e-04 | 1024 | 82 | 9 | 24711643 | |
| Pubmed | 7.32e-04 | 171 | 82 | 4 | 36629882 | ||
| Pubmed | Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7. | 7.98e-04 | 175 | 82 | 4 | 37866880 | |
| Pubmed | 8.04e-04 | 463 | 82 | 6 | 27503909 | ||
| Pubmed | Characterization of the mammalian family of DCN-type NEDD8 E3 ligases. | 8.20e-04 | 18 | 82 | 2 | 26906416 | |
| Pubmed | A physical interaction network of dengue virus and human proteins. | 8.20e-04 | 18 | 82 | 2 | 21911577 | |
| Pubmed | 8.20e-04 | 18 | 82 | 2 | 25220460 | ||
| GeneFamily | N-BAR domain containing | 4.86e-04 | 12 | 50 | 2 | 1289 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NRIP1 DCUN1D1 MIS18BP1 SLF1 GKAP1 AGGF1 SMARCAD1 DZIP1 SMC2 KIF11 SNX13 TASOR2 | 9.15e-07 | 656 | 82 | 12 | M18979 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 5.68e-06 | 142 | 82 | 6 | M39078 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ORC2 MIS18BP1 SLF1 SGO2 CKAP2 SMC2 RPA2 HELQ DIS3 KIF11 DHX9 | 8.70e-06 | 680 | 82 | 11 | MM456 |
| Coexpression | GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN | 3.34e-05 | 194 | 82 | 6 | M7573 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 3.96e-05 | 200 | 82 | 6 | M8959 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ORC2 OGFRL1 PDZD9 MIS18BP1 SLF1 TRPM7 ZNF41 SH3GL3 RBIS SGO2 SMARCAD1 DZIP1 CKAP2 CNTLN SMC2 TOE1 DHX9 ZNF292 TGS1 | 7.97e-08 | 1241 | 78 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ORC2 OGFRL1 PDZD9 MIS18BP1 SLF1 TRPM7 ZNF41 SH3GL3 RBIS SGO2 SMARCAD1 DZIP1 CKAP2 CNTLN SMC2 TOE1 DHX9 ZNF292 TGS1 | 1.05e-06 | 1468 | 78 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ORC2 MIS18BP1 ERCC6 ZNF41 SGPL1 GKAP1 ERCC6L2 SGO2 DARS1 YTHDC2 CKAP2 RPA2 DOP1A TASOR2 | 1.51e-06 | 820 | 78 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | OGFRL1 PDZD9 MIS18BP1 DST SEMA6D ZFYVE16 TRPM7 DCUN1D2 SH3GL3 ARHGEF9 GKAP1 DZIP1 CNTLN SMC2 APBB1IP DOP1A | 4.22e-06 | 1166 | 78 | 16 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | ORC2 MIS18BP1 ERCC6 ZNF41 GKAP1 SGO2 DARS1 YTHDC2 CKAP2 RPA2 DIS3 KIF11 TASOR2 | 8.58e-06 | 822 | 78 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | OGFRL1 DST SLF1 TRPM7 SYNE1 SH3GL2 SH3GL3 ARHGEF9 ERCC6L2 SGO2 SMC2 SNX13 | 2.35e-05 | 772 | 78 | 12 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.57e-05 | 258 | 78 | 7 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.01e-05 | 375 | 78 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 1.01e-04 | 395 | 78 | 8 | GSM538351_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | PDZD9 MIS18BP1 SLF1 TRPM7 ERC1 SGO2 NCKAP5 SMARCAD1 CNTLN SMC2 KIF11 ZNF292 TGS1 | 1.19e-04 | 1060 | 78 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 1.46e-04 | 417 | 78 | 8 | GSM399403_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ORC2 OGFRL1 MIS18BP1 TRPM7 ZNF41 ERC1 SGO2 SMARCAD1 DZIP1 CNTLN SMC2 TOE1 ZNF292 TGS1 | 1.68e-04 | 1252 | 78 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ORC2 OGFRL1 PDZD9 MIS18BP1 SLF1 TRPM7 SGO2 TLR7 SMARCAD1 CNTLN SMC2 KIF11 ZNF292 TGS1 | 1.75e-04 | 1257 | 78 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.05e-04 | 79 | 78 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | OGFRL1 SLF1 DCUN1D2 ERC1 SGPL1 GKAP1 ERCC6L2 GON4L NCKAP5 ZNF292 TGS1 | 2.19e-04 | 831 | 78 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | ORC2 PDZD9 MIS18BP1 MYO5B ZNF41 RBIS SMARCD1 SGO2 SMARCAD1 SMC2 DIS3 KIF11 TGS1 | 2.99e-04 | 1164 | 78 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.63e-04 | 361 | 78 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.79e-04 | 607 | 78 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MIS18BP1 TRPM7 SYNE1 SH3GL3 ARHGEF9 SGO2 DZIP1 PSTPIP2 CNTLN DOP1A | 3.84e-04 | 744 | 78 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.41e-04 | 266 | 78 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 5.34e-04 | 385 | 78 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | OGFRL1 MIS18BP1 SLF1 DCUN1D2 ERC1 SGPL1 ERCC6L2 GON4L SMC2 HELQ | 5.56e-04 | 780 | 78 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | PDZD9 MIS18BP1 SLF1 TRPM7 ERC1 SH3GL2 SGO2 NCKAP5 SMARCAD1 CNTLN SMC2 KIF11 ZNF292 TGS1 | 5.79e-04 | 1414 | 78 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.08e-04 | 105 | 78 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_1000 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 6.12e-04 | 394 | 78 | 7 | GSM777030_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | 6.44e-04 | 795 | 78 | 10 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 6.59e-04 | 399 | 78 | 7 | GSM538345_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 7.16e-04 | 806 | 78 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 7.19e-04 | 405 | 78 | 7 | GSM538343_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 7.62e-04 | 409 | 78 | 7 | GSM476663_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 7.73e-04 | 410 | 78 | 7 | GSM538387_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | PWWP2A NRIP1 MIS18BP1 TRPM7 GLIPR2 YTHDC2 SMARCAD1 SMC2 ZFX TGS1 | 7.80e-04 | 815 | 78 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ORC2 OGFRL1 PDZD9 MIS18BP1 SLF1 TRPM7 SGO2 TLR7 SMARCAD1 CNTLN SMC2 KIF11 ZNF292 TGS1 | 7.88e-04 | 1459 | 78 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 7.95e-04 | 412 | 78 | 7 | GSM605793_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | OGFRL1 DCUN1D1 MIS18BP1 ARHGEF9 ERCC6L2 LGR4 SGO2 DZIP1 ZNF227 CNTLN | 8.09e-04 | 819 | 78 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_200 | 8.75e-04 | 51 | 78 | 3 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_200_k4 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 8.78e-04 | 419 | 78 | 7 | GSM538348_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 9.15e-04 | 422 | 78 | 7 | GSM399442_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 9.15e-04 | 422 | 78 | 7 | GSM476658_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 9.15e-04 | 422 | 78 | 7 | GSM538357_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 9.15e-04 | 422 | 78 | 7 | GSM538355_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 9.28e-04 | 423 | 78 | 7 | GSM476655_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 9.28e-04 | 423 | 78 | 7 | GSM791126_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNE1 SH3GL3 ARHGEF9 SGO2 DZIP1 PSTPIP2 CNTLN SMC2 DOP1A TGS1 | 9.30e-04 | 834 | 78 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | ORC2 PDZD9 MIS18BP1 MYO5B ZNF41 RBIS SMARCD1 SGO2 SMARCAD1 SMC2 DIS3 KIF11 TGS1 | 1.18e-03 | 1347 | 78 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.31e-03 | 129 | 78 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-08 | 197 | 82 | 7 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.27e-08 | 198 | 82 | 7 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-07 | 168 | 82 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-07 | 171 | 82 | 6 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-07 | 172 | 82 | 6 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.42e-07 | 174 | 82 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.00e-07 | 176 | 82 | 6 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-07 | 179 | 82 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-06 | 180 | 82 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.17e-06 | 184 | 82 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-06 | 185 | 82 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 82 | 6 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 1.49e-06 | 192 | 82 | 6 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.54e-06 | 193 | 82 | 6 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.54e-06 | 193 | 82 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.54e-06 | 193 | 82 | 6 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-06 | 194 | 82 | 6 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-06 | 194 | 82 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-06 | 194 | 82 | 6 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.59e-06 | 194 | 82 | 6 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-06 | 194 | 82 | 6 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-06 | 194 | 82 | 6 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.59e-06 | 194 | 82 | 6 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.59e-06 | 194 | 82 | 6 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-06 | 197 | 82 | 6 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 1.89e-06 | 200 | 82 | 6 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.89e-06 | 200 | 82 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 1.89e-06 | 200 | 82 | 6 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 1.89e-06 | 200 | 82 | 6 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Stem_cells|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 13636463e44a99cd886926340bfb35880f95cca6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Stem_cells-Neuroepithelial_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 2a3874634cc4357a64ef9fd4a6bbdfd84236ebac | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.10e-06 | 129 | 82 | 5 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 163 | 82 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 167 | 82 | 5 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 168 | 82 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 169 | 82 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 169 | 82 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 169 | 82 | 5 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 169 | 82 | 5 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-05 | 170 | 82 | 5 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-05 | 170 | 82 | 5 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-05 | 170 | 82 | 5 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-05 | 171 | 82 | 5 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 172 | 82 | 5 | 1171e754fd503a0c1152162fcc12a115088a08c7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 172 | 82 | 5 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 172 | 82 | 5 | 35c20de4db47dbf31c857d23c7a25cd7f95c085c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 174 | 82 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 174 | 82 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 175 | 82 | 5 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 175 | 82 | 5 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 175 | 82 | 5 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 176 | 82 | 5 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 176 | 82 | 5 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 176 | 82 | 5 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 177 | 82 | 5 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 1.90e-05 | 177 | 82 | 5 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 177 | 82 | 5 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 177 | 82 | 5 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 177 | 82 | 5 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-05 | 179 | 82 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-05 | 180 | 82 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-05 | 180 | 82 | 5 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-05 | 181 | 82 | 5 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-05 | 181 | 82 | 5 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-05 | 181 | 82 | 5 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-05 | 181 | 82 | 5 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-05 | 181 | 82 | 5 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 182 | 82 | 5 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 182 | 82 | 5 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 182 | 82 | 5 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-05 | 184 | 82 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-05 | 184 | 82 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.29e-05 | 184 | 82 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.29e-05 | 184 | 82 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.29e-05 | 184 | 82 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.29e-05 | 184 | 82 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 184 | 82 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-05 | 184 | 82 | 5 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.35e-05 | 185 | 82 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 185 | 82 | 5 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 185 | 82 | 5 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.35e-05 | 185 | 82 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 185 | 82 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 186 | 82 | 5 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 186 | 82 | 5 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 187 | 82 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 2.54e-05 | 188 | 82 | 5 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 188 | 82 | 5 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.54e-05 | 188 | 82 | 5 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 188 | 82 | 5 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.40e-04 | 7 | 77 | 2 | C0751337 | |
| Disease | diabetes mellitus biomarker | 2.98e-04 | 10 | 77 | 2 | EFO_0006842 | |
| Disease | psychological resilience measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0009945 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 8.91e-04 | 17 | 77 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Feeding difficulties | 1.00e-03 | 18 | 77 | 2 | C0232466 | |
| Disease | event free survival time, urinary bladder cancer | 1.12e-03 | 19 | 77 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | Infiltrating duct carcinoma of female breast | 1.37e-03 | 21 | 77 | 2 | C3165106 | |
| Disease | prostate carcinoma | 2.24e-03 | 891 | 77 | 8 | EFO_0001663 | |
| Disease | Mental Retardation, X-Linked | 2.61e-03 | 29 | 77 | 2 | C1136249 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKSQKEKHRHSKMKI | 66 | A8MVM7 | |
| QKKNCKMQKSSHTAV | 946 | Q9NXG0 | |
| EAAKMKKIKFQHIVS | 71 | Q8NFD2 | |
| KKLVVKVHMNDNSTK | 176 | Q7Z5R6 | |
| ENFANMKKKAKIGIH | 311 | Q8N302 | |
| SNAFPNKDMKLENHK | 2426 | Q5JWR5 | |
| TQSKVMNKKDKRKNH | 156 | Q5VSY0 | |
| DNIKKAFSKENMQKT | 196 | Q5BKX8 | |
| MNKLKSSQKDKVRQF | 1 | Q96GG9 | |
| NKQMENNFYKHKSKT | 1171 | Q03468 | |
| VSMKNAFKLHNKETE | 386 | O43307 | |
| QAFHLKNNSKKKQMT | 146 | Q8WWK9 | |
| SHSKFMKNKVEQLKE | 431 | Q8IUD2 | |
| IHKQKSLQFKKTMDA | 126 | Q9H939 | |
| LTFDKNENMAAKKKS | 176 | O14775 | |
| LHSQNTSLINQKKKM | 1716 | P12883 | |
| HNSQTSMHKKAKDSK | 336 | Q5TC84 | |
| NDHKKNQFLKMTTFN | 56 | Q6P0N0 | |
| MNNVSFKIKHSNEKK | 581 | Q86W26 | |
| NNVKKLQKFASTVKM | 26 | Q8N335 | |
| HSKKFCLENMTQKFK | 5051 | Q03001 | |
| QKSKDIVNKMTFHSQ | 756 | P52732 | |
| MHKLKSSQKDKVRQF | 1 | Q6PH85 | |
| KSFKEKFMKCLHNNN | 31 | Q49B96 | |
| NQEVKASMKKVFNKH | 291 | Q8NGD1 | |
| MQKASHKNKKERGVS | 1 | Q8IXQ8 | |
| SMEKNEHFLQKLGKK | 71 | Q6UY01 | |
| KKMKNNIVDAANNHS | 871 | P48552 | |
| MKNGKSNHLKQFRVA | 651 | Q9BXB1 | |
| KTFSVSLQKQNKMKF | 226 | Q8TAG9 | |
| KMKDTSKKNNIFAQF | 761 | Q8TAG9 | |
| MGKSASKQFHNEVLK | 1 | Q9H4G4 | |
| ENFNKESKKSNLLKM | 31 | Q5TBE3 | |
| FEQLKMKKSSAKQLQ | 651 | Q3T8J9 | |
| MKESPHFQKSKATQI | 821 | Q8IY85 | |
| MLSQKTKKKHNFLNH | 1 | Q9BQD1 | |
| MAKQKQKSFKAHISV | 1581 | Q9ULL0 | |
| QSRHQFKTEAAAMKK | 311 | Q86UT8 | |
| KLTQEQKTKHCMFSL | 126 | Q6ZN92 | |
| KKELHNSPKTMNKTN | 1021 | Q5T890 | |
| HKKKQRTNFLEKMAT | 101 | A6NE01 | |
| KDHLKNAMTGNAKAQ | 266 | Q8TDG4 | |
| VFHKAQKGEKQAMKN | 1696 | Q8IVF4 | |
| QLQHKEKKLSASQMA | 36 | Q8N7B9 | |
| SCKQKVKLFTAHNNM | 731 | Q08211 | |
| SFQNRKHSEKMAKLA | 96 | Q13416 | |
| NKLHSRSKQMQKYKQ | 941 | Q9Y5W8 | |
| QLSTKKVLQSKNMDH | 411 | Q96N64 | |
| MESIKKKNNKASAFR | 1351 | O95602 | |
| MSVAGLKKQFHKASQ | 1 | Q99963 | |
| TKLKQKFSMKAQNGF | 326 | Q9H4L7 | |
| VQNRNHNAKKKKMAD | 116 | Q96GM5 | |
| SKHETAKNKMNYKQK | 2126 | Q8NF91 | |
| STQGNHKKNMKIKAD | 1661 | O14513 | |
| SNKKTNEHGMKTFRK | 386 | Q562F6 | |
| HASKQMVKFAANINK | 96 | P14868 | |
| HIASQKNFKAKNKAK | 16 | Q8N0T1 | |
| MNHNAEILKTKFTKS | 566 | Q9Y2L1 | |
| NNNKMHLRKALKSNS | 521 | Q86YF9 | |
| KLNKTKDDISKNMSF | 91 | O95470 | |
| HMFLEKGNKKNSTTN | 1136 | A0JNW5 | |
| VETMKKLTQNHKAKG | 26 | Q6P1L6 | |
| GRAFAQKSNVKKHMQ | 356 | Q9BYN7 | |
| KNQLKHMSVSSIKQA | 231 | P15927 | |
| IKSAQKAHNSVNKMG | 56 | Q96T58 | |
| MSVAGLKKQFHKATQ | 1 | Q99962 | |
| SSNKQKMLEAHIKTF | 896 | Q6ZQQ2 | |
| MNHNKFVKCKKTSAV | 376 | X6R8R1 | |
| NMSSKANQEKSKSKH | 2301 | O60281 | |
| KQNKKLASYMNKPHS | 1401 | Q8IZH2 | |
| THMLNFTKNLKVLQK | 586 | Q9NYK1 | |
| KKMNFHKTNLKGETA | 796 | Q9BQI6 | |
| KAQTEAKQAQMKLKH | 411 | O95347 | |
| LHSNMQTSDQKKVLK | 661 | Q9H6S0 | |
| KAFTDRSNLIKHQKM | 796 | P51814 | |
| KGFRQQSELKKHMKT | 726 | P17010 | |
| SSKHQNKMETLQKFA | 91 | Q86WZ6 | |
| EKAFNQKSALQVHMK | 1756 | Q9UL36 | |
| AHKKNIMLKSFQSAN | 2336 | Q5VWN6 | |
| QINLKTNIHFKKMAS | 61 | A6NDI0 | |
| RQIKMKNKHIFFTKE | 486 | Q96RS0 | |
| HQKTLQAMKSHSEKA | 781 | Q8NFY4 | |
| QFSRSSKAHNQKMKL | 491 | Q96GM8 | |
| KKEKMRHNHFIKTAQ | 571 | Q96QT4 | |
| QSSKMFHAKDKLQHK | 251 | Q7Z3T8 | |
| MKVSNKEHKKTVGHQ | 621 | Q9ULV0 |